Perfusate oncotic pressure during cardiopulmonary bypass. Optimum level as determined by metabolic acidosis, tissue edema, and renal function.
Current practice with respect to the use of a dilutional prime for cardiopulmonary bypass (CPB) varies widely, and the safe lower limit of perfusate protein content has not been defined. We studied this question in 75 rabbits subjected to a 1-hour CPB with a perfusate colloid osmotic pressure (COP) ranging from 26 to 4 mm Hg. Metabolic acidosis was inversely related to COP; acid-base equilibrium is thus best maintained with a high perfusate protein content. Tissue edema rapidly increased at COP levels below 16 mm Hg, i.e. with a protein level less than 4.2 g%. Urinary excretion during CPB was antagonized by the COP, the reason being that glomerular filtration rate was proportional to the difference between perfusion pressure and COP. The safety margin for renal function during CPB thus widens with a decreasing perfusate protein content. We conclude that the optimum levels of perfuste oncotic pressure and protein content during experimental cardiopulmonary bypass are 16 mm Hg and 4.2 g%.
D000136:Acid-Base Equilibrium; D000138:Acidosis / Q000378:metabolism*; D000818:Animals; D002315:Cardiopulmonary Bypass; D003404:Creatinine / Q000097:blood; D004487:Edema / Q000503:physiopathology*; D005665:Furosemide / Q000494:pharmacology; D005919:Glomerular Filtration Rate; D007668:Kidney / Q000503:physiopathology*; D007773:Lactates / Q000097:blood; D009997:Osmotic Pressure; D010477:Perfusion; D011817:Rabbits; D014882:Water-Electrolyte Balance
D007773:Lactates; D005665:Furosemide; D003404:Creatinine